(Q30465168)

English

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

scientific article

Statements

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis (English)
Dominique Thabut
Chittaranjan Routray
Robert Huebert
Tetyana Masyuk
Boris Blechacz
Andrew Vercnocke
Richard Ehman

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit